Interventional Spine gets EU nod to double market opportunity:
This article was originally published in Clinica
In what more than doubles the market potential for its Percudyn dynamic stabilisation device outside the US, Interventional Spine has received European approval to expand the indications for the device. In addition to its original 2006 clearance for degenerative disc disease, the percutaneous product can be used to treat a number of conditions including neurogenic intermittent claudication due to lumbar spinal stenosis, spondylolisthesis and Baastrup's syndrome. The Percudyn system is to be launched at this months Spine Arthroplasty Society meeting in Berlin, Germany, said the the Irvine, California firm.